Articles tagged "Survival"

2020 American Transplant Congress
Hydroxychloroquine is Associated with Better Patient and Graft Survival in Kidney Transplant Patients with Lupus Nephritis as Cause of ESRD
T. Singh¹, S. Garg², S. Panzer¹
¹Nephrology, University of Wisconsin, Madison, WI, ²Rheumatology, University of Wisconsin, Madison, WI
*Purpose: Hydroxychloroquine (HCQ) use leads to better patient and renal survival in patients with lupus nephritis (LN). Whether the clinical benefits of HCQ extends to…
2020 American Transplant Congress
Development of Self-Limited Low-Level BK Viremia/Viruria Suggests Ideal Immunosuppression to Suppress T-Cell and Antibody-Mediated Rejection and to Preserve Kidney Allograft Function
B. Näf, T. Müller, R. Wüthrich, T. Schachtner
University Hospital Zurich, Zurich, Switzerland
*Purpose: Polyomavirus BK (BKV) has been suggested as a surrogate marker of overimmunosuppression. Due to recent advances in monitoring strategies and pre-emptive therapy, progression to…
2020 American Transplant Congress
Amiodarone Use in Lung Transplant Recipients with New Onset Atrial Arrhythmias
E. Klipsch¹, R. Rachwan², I. KutKut³, D. Roe², C. Hage², T. Hathaway¹, R. S. Mangus²
¹Indiana University School of Medicine, Indianapolis, IN, ²IU Health, Indianapolis, IN, ³New York Presbyterian Hospital, New York, NY
*Purpose: Atrial arrhythmias occur in 16-46% of patients after lung transplant, and most of these are atrial fibrillation or flutter. Standard therapy is described as…
2020 American Transplant Congress
Survival with Post-Transplant Diabetes Mellitus is Worse after Heart Transplantation
K. Y. Feng¹, E. Henricksen², Y. Moayedi³, R. Lee², J. Han¹, S. Purewal¹, A. Puing¹, M. Basina¹, J. J. Teuteberg¹, K. K. Khush¹
¹Medicine, Stanford University, Palo Alto, CA, ²Pharmacy, Stanford University, Palo Alto, CA, ³Cardiology, University Health Network, Toronto, ON, Canada
*Purpose: An increasing number of patients undergoing heart transplantation (HTx) have diabetes mellitus (DM). However, there is limited data on clinical outcomes after HTx in…
2020 American Transplant Congress
Effect of Increased Recipient Age on Solid-Organ Pancreas Transplantation Outcomes: A Systematic Review
J. E. Ling
Nephrology, Monash Medical Centre, Clayton, Australia
*Purpose: Increased recipient age has been associated with poorer solid organ pancreas transplant (SOPTx) outcomes. We hypothesized that recipient age cut-offs in Australia and New…
2020 American Transplant Congress
Low Physiochemical Immunogenicity Scores Improve Long-Term Survival of Deceased Donor Kidney Transplants
D. Bekbolsynov¹, B. Mierzejewska¹, J. Borucka², S. A. Khuder¹, M. Rees¹, R. Green³, S. Stanislaw¹
¹University of Toledo, Toledo, OH, ²Parexel Corp., Warsaw, Poland, ³Bowling Green State University, Bowling Green, OH
*Purpose: A severe shortage of deceased donor kidneys limits access to kidney transplantation. Limited longterm graft function exacerbates this shortage as 12% of the waiting…
2020 American Transplant Congress
The Living Donor Collective Pilot Evaluations of Living Kidney Donor Candidates at 10 Programs
B. Kasiske, M. Conboy, Y. Ahn, A. Israni, J. Snyder
SRTR, Minneapolis, MN
*Purpose: Much remains to learn regarding long-term effects of living organ donation on donors. Rare events are important, and long-term follow-up with appropriate contemporaneous controls…
2020 American Transplant Congress
Optimal Transition for Transplant Recipients: A Model of Care in an Integrated Health Care System
S. Zheng¹, L. Pravoverov¹, A. Nazarova¹, D. Adey², N. B. Goes¹
¹The Permanente Medical Group, San Francisco, CA, ²Kidney and Transplantation Program, University of California San Francisco, San Francisco, CA
*Purpose: Transplantation is the treatment of choice for ESRD. While short-term outcomes have improved, long-term outcomes lag. Many factors may explain the long-term lag including…
2020 American Transplant Congress
Results of Pancreas Transplantation in Diabetic Patients with End-Stage Kidney Disease Older Than 50 Years
E. Montagud-Marrahi¹, A. Molina², A. Pané³, M. Ramirez-Bajo⁴, A. Amor³, E. Esmatjes³, J. Ferrer⁵, F. Diekmann¹, P. Ventura-Aguiar¹
¹Nephrology and Kidney Transplantation Department, Hospital Clínic de Barcelona, Barcelona, Spain, ²Servei de Nefrologia i Trasplantament Renal, Hospital Clínic de Barcelona, Barcelona, Spain, ³Endocrinology Department, Hospital Clínic de Barcelona, Barcelona, Spain, ⁴Laboratori Experimental de Nefrologia I Trasplantament (LENIT), CRB CELLEX, Fundació Clínic, IDIBAP, Hospital Clínic de Barcelona, Barcelona, Spain, ⁵Hepatobiliopancreatic and Liver Transplant Department, Hospital Clínic de Barcelona, Barcelona, Spain
*Purpose: Improvement of care in type 1 diabetes mellitus, with the optimization of patient access to insulins of variable action, has led to macro- and…
2020 American Transplant Congress
Heart Transplant Outcomes for Patients with Left Ventricular Assist Devices (LVAD) Before and after the 2018 Revision of the United Network for Organ Sharing (UNOS) Adult Heart Allocation System
J. Pizula¹, K. Yang¹, J. Li¹, S. Shah¹, G. Liu¹, A. Lee¹, P. Banankhah¹, J. Nattiv¹, D. Miklin¹, P. Genyk¹, P. Kingsford¹, K. Pandya¹, R. Joeseph¹, M. Fong¹, G. Luanda¹, A. Kiankhooy¹, S. Hashmi¹, S. Nuno¹, A. Wolfson², A. Salimbangon³, R. Chand⁴, D. Vucicevic⁵, L. Corey⁶, E. Depasquale¹, A. Vaidya¹
¹Cardiology, LAC-USC, Los Angeles, CA, ²University of Arizona Sarver Heart Center, Tuscon, AZ, ³UCLA Medical Center, Los Angeles, CA, ⁴Harbor-UCLA Medical Center, Los Angeles, CA, ⁵Newark Beth-Israel Medical Center, Newark, NJ, ⁶The Queen's Medical Center, Honolulu, HI
*Purpose: In October of 2018 UNOS chaged their adult heart allocation criteria to address disparity in waiting list survival. The implications of this policy change…